Clinical Trial Update: SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults [Phase 3]

View source ↗

Summary

Phase 3 trial (SYMPHONIE) comparing a Symbicort single inhaler to conventional best practice for persistent asthma in adolescents and adults has completed. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED